Institutionalizing Misinformation - The Dietary Supplement Listing Act of 2022

N Engl J Med. 2022 Jul 7;387(1):3-5. doi: 10.1056/NEJMp2205675. Epub 2022 May 18.

Authors

Pieter A Cohen¹, Jerry Avorn¹, Aaron S Kesselheim¹

Affiliation

¹ From Cambridge Health Alliance, Somerville (P.A.C.), and Harvard Medical School (P.A.C., J.A., A.S.K.) and the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (J.A., A.S.K.), Boston - all in Massachusetts.

PMID: 35584146
DOI: 10.1056/NEJMp2205675

No abstract available

MeSH terms

Communication
Dietary Supplements*
Humans
Legislation, Food*
United States
United States Food and Drug Administration* / legislation & jurisprudence